http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-036310-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2e2930d121efc5d86e61f3b89a4f5ea |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0039 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate | 2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-036310-A1 |
titleOfInvention | A SUPPLY SYSTEM |
abstract | A delivery system comprising a core and a membrane encapsulating said core, wherein said core and said membrane essentially consist of an equal or different elastomer composition, wherein said core comprises at least two therapeutically active agents, each of which which has a release speed. The membrane can consist of at least two layers, the thickness of which can be different and also comprises a space that separates at least two parts of the core. Said separation membrane essentially consists of an elastomer composition, the separation membrane being permeable or impermeable to at least one of the therapeutically active agents. The elastomer composition is selected from the group consisting of: an elastomer composition comprising poly (dimethylsiloxane); an elastomer composition comprising a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Si atoms of the siloxane units; an elastomer composition comprising poly (alkylene oxide) groups, wherein said poly (alkylene oxide) groups are present as alkoxy terminated grafts or blocks attached to the polysiloxane units via silicon-carbon bonds, or as a mixture in these ways; and a combination of at least two of them. The release rates of the at least two active therapeutic agents are identical or different. The delivery system can be an implant, an intrauterine system, an intracervical system or an intravaginal system, and the therapeutically active agent can be a hormone. |
priorityDate | 2001-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433298 |
Total number of triples: 31.